Hilary Cannon

Title: Hilary Cannon - Innovator in Pharmaceutical Chemistry

Introduction

Hilary Cannon is a notable inventor based in Hertfordshire, GB. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. Her work focuses on creating effective treatments for cardiovascular diseases.

Latest Patents

Hilary Cannon holds a patent for a compound titled [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto. This invention provides novel sulfonylurea compounds and their pharmaceutically acceptable derivatives. The compounds are effective platelet ADP receptor inhibitors and can be utilized in various pharmaceutical compositions, particularly for the prevention and treatment of cardiovascular diseases related to thrombosis.

Career Highlights

Hilary Cannon has established herself as a key figure in her field through her innovative research and development efforts. Her patent reflects her commitment to advancing medical science and improving patient outcomes. She is currently associated with Portola Pharmaceuticals, Inc., where she continues to contribute to the development of groundbreaking therapies.

Collaborations

Hilary has collaborated with notable professionals in her field, including Robert M. Scarborough and Carroll Scarborough, who serves as her legal representative. These collaborations have further enhanced her work and the impact of her inventions.

Conclusion

Hilary Cannon's contributions to pharmaceutical chemistry exemplify her dedication to innovation and improving healthcare. Her patented work on sulfonylurea compounds showcases her ability to address critical medical challenges.